Department of Anesthesiology

You are here

Publications

Author Title [ Type(Desc)] Year
Filters: Keyword is Succinylcholine  [Clear All Filters]
Journal Article
Savarese JJ, Lien CA, Belmont MR, Rubin L.  1995.  The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.. Acta Anaesthesiol Scand Suppl. 106:18-22.
Ramsey FM, Lebowitz PW, Savarese JJ, Ali HH.  1980.  Clinical characteristics of long-term succinylcholine neuromuscular blockade during balanced anesthesia.. Anesth Analg. 59(2):110-6.
Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ.  2004.  Clinical pharmacology of GW280430A in humans.. Anesthesiology. 100(4):768-73.
Lebowitz PW, Savarese JJ.  1980.  Complications involving neuromuscular pharmacology.. Int Anesthesiol Clin. 18(3):139-56.
Fahmy NR, Gissen AJ, Savarese JJ, Kitz RJ.  1975.  Decamethonium and serum potassium in man.. Anesthesiology. 42(6):692-7.
Kopman AF, Lien CA, Naguib M.  2010.  Determining the potency of neuromuscular blockers: are traditional methods flawed? Br J Anaesth. 104(6):705-10.
Lien CA, Belmont MR, Heerdt PM.  2005.  GW280430A: pharmacodynamics and potential adverse effects.. Anesthesiology. 102(4):861-2;authorreply862-3.
Riker WF, Okamoto M, Artusio JF.  1995.  In vivo reversal of depolarizing neuromuscular blockade.. Arch Int Pharmacodyn Ther. 330(1):90-101.
D'Ambra MN, Dedrick D, Savarese JJ.  1979.  Kearns-Sayer syndrome and pancuronium--succinylcholine-induced neuromuscular blockade.. Anesthesiology. 51(4):343-5.
Savarese JJ, Todd D.  1973.  Letter: Succinylcholine effects in anesthesia.. JAMA. 226(11):1359-60.
Kopman AF, Klewicka MM, Kopman DJ, Neuman GG.  1999.  Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.. Anesthesiology. 90(2):425-31.
Ali HH, Savarese JJ.  1976.  Monitoring of neuromuscular function.. Anesthesiology. 45(2):216-49.
Mitchell MM, Ali HH, Savarese JJ.  1978.  Myotonia and neuromuscular blocking agents.. Anesthesiology. 49(1):44-8.
Ginsburg S, Kitz RJ, Savarese JJ.  1971.  Neuromuscular blocking activity of a new series of quaternary N-substituted choline esters.. Br J Pharmacol. 43(1):107-26.
Okamoto M, Walewski JL, Artusio JF, Riker WF.  1992.  Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.. Anesth Analg. 75(3):361-71.
Savarese JJ, Ginsburg S, Lee SM, Kitz RJ.  1973.  The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications.. Anesth Analg. 52(6):982-8.
Naguib M, Lien CA, Aker J, Eliazo R.  2004.  Posttetanic potentiation and fade in the response to tetanic and train-of-four stimulation during succinylcholine-induced block.. Anesth Analg. 98(6):1686-91,tableofcontents.
Savarese JJ, Antonio RP, Ginsburg S.  1975.  Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments.. Anesth Analg. 54(5):669-78.
Yao FS, Savarese JJ.  1997.  Pseudocholinesterase hyperactivity with succinylcholine resistance: an unusual cause of difficult intubation.. J Clin Anesth. 9(4):328-30.
Savarese JJ, Kitz RJ.  1973.  The quest for a short-acting nondepolarizing neuromuscular blocking agent.. Acta Anaesthesiol Scand Suppl. 53:43-58.
Kelly RE, Dinner M, Turner LS, Haik B, Abramson DH, Daines P.  1993.  Succinylcholine increases intraocular pressure in the human eye with the extraocular muscles detached.. Anesthesiology. 79(5):948-52.
Savarese JJ, Ali HH, Murphy JD, Padget C, Lee CM, Ponitz J.  1975.  Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine.. Anesthesiology. 42(1):106-11.